TY - JOUR
T1 - An evolving perspective on novel modified release drug delivery systems for inhalational therapy
AU - Hye, Tanvirul
AU - Moinuddin, Sakib M
AU - Sarkar, Tanoy
AU - Nguyen, Trieu
AU - Saha, Dipongkor
AU - Ahsan, Fakhrul
PY - 2023
Y1 - 2023
N2 - Drugs delivered via the lungs are predominantly used to treat various respiratory disorders, including asthma, chronic obstructive pulmonary diseases, respiratory tract infections and lung cancers, and pulmonary vascular diseases such as pulmonary hypertension. To treat respiratory diseases, targeted, modified or controlled release inhalation formulations are desirable for improved patient compliance and superior therapeutic outcome.
AB - Drugs delivered via the lungs are predominantly used to treat various respiratory disorders, including asthma, chronic obstructive pulmonary diseases, respiratory tract infections and lung cancers, and pulmonary vascular diseases such as pulmonary hypertension. To treat respiratory diseases, targeted, modified or controlled release inhalation formulations are desirable for improved patient compliance and superior therapeutic outcome.
M3 - Review article
VL - 20
SP - 335
EP - 348
JO - Expert opinion on drug delivery
JF - Expert opinion on drug delivery
IS - 3
ER -
